The UK relative to other single payer-dominated healthcare markets for regenerative medicine therapies. (2012)
Attributed to:
EPSRC Centre for Innovative Manufacturing in Regenerative Medicine
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2217/rme.11.125
PubMed Identifier: 22594333
Publication URI: http://europepmc.org/abstract/MED/22594333
Type: Journal Article/Review
Volume: 7
Parent Publication: Regenerative medicine
Issue: 3
ISSN: 1746-0751